These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20609191)

  • 21. Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis.
    Hanken I; Schimmer M; Sander CA
    J Dtsch Dermatol Ges; 2010 May; 8(5):341-6. PubMed ID: 19845819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
    Halevy S
    Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic epidermal necrolysis: 15 years' experience in a Dutch burns centre.
    Gerdts B; Vloemans AF; Kreis RW
    J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):781-8. PubMed ID: 17567308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxic epidermal necrolysis-like cutaneous lupus erythematosus: A series of three patients.
    Cisneros CG; Romiti R; Santi CG; Aoki V; Valente NY; Nico MM
    Acta Derm Venereol; 2010 Mar; 90(2):175-8. PubMed ID: 20169302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
    Abe R
    J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
    Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre.
    Rajaratnam R; Mann C; Balasubramaniam P; Marsden JR; Taibjee SM; Shah F; Lim R; Papini R; Moiemen N; Lewis H
    Clin Exp Dermatol; 2010 Dec; 35(8):853-62. PubMed ID: 20456393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facing up to toxic epidermal necrolysis.
    Piérard GE; Paquet P
    Expert Opin Pharmacother; 2010 Oct; 11(15):2443-6. PubMed ID: 20707598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.
    Yip LW; Thong BY; Tan AW; Khin LW; Chng HH; Heng WJ
    Eye (Lond); 2005 Aug; 19(8):846-53. PubMed ID: 15389280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burn center care for patients with toxic epidermal necrolysis.
    Kelemen JJ; Cioffi WG; McManus WF; Mason AD; Pruitt BA
    J Am Coll Surg; 1995 Mar; 180(3):273-8. PubMed ID: 7874336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
    Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
    Stella M; Clemente A; Bollero D; Risso D; Dalmasso P
    Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic epidermal necrolysis induced by sulfonamide eyedrops.
    Fine HF; Kim E; Eichenbaum KD; Antoniades K; Williams CA
    Cornea; 2008 Oct; 27(9):1068-9. PubMed ID: 18812774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus.
    Jongen-Lavrencic M; Schneeberger PM; van der Hoeven JG
    Infection; 2003 Dec; 31(6):428-9. PubMed ID: 14735388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic epidermal necrolysis.
    Pereira FA; Mudgil AV; Rosmarin DM
    J Am Acad Dermatol; 2007 Feb; 56(2):181-200. PubMed ID: 17224365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome).
    Paquet P; Piérard GE; Quatresooz P
    Int Arch Allergy Immunol; 2005 Mar; 136(3):205-16. PubMed ID: 15713983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic epidermal necrolysis: a burn-centre challenge.
    Peters W; Zaidi J; Douglas L
    CMAJ; 1991 Jun; 144(11):1477-80. PubMed ID: 2032200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.